USA 112 , E2245E2252 (2015)
GLP-1 medications improve insulin sensitivity and reduce hyperinsulinemia, shifting the hormonal environment away from growth-factorrich conditions that may favor lesion survival
There is also a trial specifically testing whether retatrutide prevents heart attacks and strokes (TRIUMPH-3, 1,800 people), and a head-to-head trial comparing retatrutide directly against tirzepatide (the active ingredient in Zepbound) under identical conditions (NCT06662383, 800 patients)
Primarily prescribed for type 2 diabetes, Ozempic has also been used off-label for weight management
Some patients report mild diarrhoea, nausea, or headache following administration, though these symptoms are usually transient
A recent study has discovered that adenosine can activate brown fat cells in mice through the A2a receptor, thereby preventing obesity due to a high-fat diet [11]